Amkay Products IPO GMP: Should You Apply? Here’s What Expert Said – Check Subscription Status And Other Details (image source: Amkay Products)
Amkay Products IPO GMP: The intial public offering(IPO) of Amkay Products subscriptions window scheduled to close tommorow i.e. on May 03, 20204. The IPO has received overwhelming response form the investors in last two days. Check subscription status, expert insight and other IPO deatais.
Should You Apply For Amkay Products IPO?
“Amidst a challenging landscape intensified by the pandemic, Amkay faces hurdles within an already crowded sector. Its financial performance has been inconsistent, with core revenue streams showing decline in recent years. Investors should note that the stock is currently priced to reflect its existing prospects, offering limited potential for substantial returns in the near future.
Projected earnings for 2024 suggest that the stock’s potential short-term gains are already factored into its value. While some financial maneuvers may aim to improve its appearance, these raise doubts about the reliability of its financial statements. Despite backing from a reputable underwriter, investors should evaluate IPOs basis the issuer company’s own merits,” said Tarun Singh, MD, Highbrow Securities.
Amkay Products IPO Subscription Status
The Amkay Products IPO saw a subscription rate of 213.07 times overall. In the retail category was oversubscribed by an impressive 332.51 times, while the Qualified Institutional Buyers (QIB) category saw a subscription of 0.79 times, and the Non-Institutional Investors (NII) category subscribed by 216.49 times by May 2, 2024, 7:02:04 PM.
Amkay Products IPO Subscription Timeline
The Amkay Products IPO opens for subscription on April 30, 2024, and concludes on May 3, 2024.
Amkay Products IPO Allotment Date
Allotment of shares for the Amkay Products IPO is expected to be finalized on Monday, May 6, 2024.
Amkay Products IPO Listing Date
The IPO is slated to list on BSE SME, with a tentative listing date scheduled for Wednesday, May 8, 2024.
Amkay Products IPO Price Band
The price band for the Amkay Products IPO is set at Rs 52 to Rs 55 per share.
Amkay Products IPO GMP Today: Check Latest GMP
According to various unlisted market tracking websites, the grey market premium (GMP) price ranges from Rs 45 to Rs 55 per share.
Amkay Products IPO Lot Size
The minimum lot size for an application is 2000 shares.
Amkay Products IPO Minimum Invest Criteria
– Retail investors are required to invest a minimum amount of Rs 110,000 to participate in the IPO.
– High Net Worth Individuals (HNIs) can invest in 2 lots (4,000 shares), amounting to Rs 220,000.
Amkay Products IPO Book Running Lead Manager and Registrar
– Hem Securities Limited serves as the book-running lead manager for the Amkay Products IPO.
– Bigshare Services Pvt Ltd is appointed as the registrar for the issue.
– Hem Finlease has been designated as the market maker for the Amkay Products IPO, facilitating trading activities.
About Amkay Products
Amkay Products Limited is a healthcare company offering a diverse range of medical devices, disposables, and essential healthcare items such as face masks, alcohol swabs, lancet needles, nebulizers, and more. Our products cater to healthcare centers, hospitals/clinics, nursing homes, and similar facilities across India. With over 30 healthcare products in our portfolio, including medical devices for respiratory diseases, surgical disposables, and home healthcare products, we ensure comprehensive healthcare solutions. Our manufacturing facility, spanning 26,000 sq. ft. in Thane, Maharashtra, is equipped with advanced machinery and a testing lab, maintaining ISO 9001:2015 standards for quality. With two manufacturing units and a warehouse in Thane, Maharashtra, we employ approximately 75 dedicated professionals committed to delivering quality healthcare products.
(Disclaimer: The above article is meant for informational purposes only, and should not be considered as any investment advice. Today Technology Market ResearchDigital suggests its readers/audience to consult their financial advisors before making any money related decisions.)
